Jullian G. Jones

ullian joined Monte Rosa from Eli Lilly and Company, where she served as Senior Director of Oncology Business Development. Jullian led the identification and strategic assessment of in-licensing and M&A oncology opportunities across the clinical and preclinical portfolio, as well as out-licensing activities across the oncology portfolio. She was pivotal in leading several oncology M&A activities at Lilly, including the $8 billion acquisition of Loxo Oncology. Prior to Lilly, Jullian served in several leadership roles at Boehringer Ingelheim, including business development and licensing, marketing and new product planning. Jullian began her life sciences business development career at Columbia Technology Ventures (CTV). At CTV, she was also responsible for facilitating the spin-off of early-phase companies. Jullian has a Ph.D. from Johns Hopkins University, a J.D. from Georgetown Law Center and an MBA from Columbia University.